Your browser doesn't support javascript.
loading
Alpha-2 macroglobulin activity in SARS-CoV-2 induced infection and in the post-COVID-19 period.
Akbasheva, O E; Mitrofanova, D K; Spirina, L V; Samoilova, Yu G; Matveeva, M V; Podchinenova, D V; Oleynik, O A.
Affiliation
  • Akbasheva OE; Siberian State Medical University, Tomsk, Russia.
  • Mitrofanova DK; Siberian State Medical University, Tomsk, Russia.
  • Spirina LV; Siberian State Medical University, Tomsk, Russia; Cancer Research Institute, Tomsk National Research Medical Center, Tomsk, Russia.
  • Samoilova YG; Siberian State Medical University, Tomsk, Russia.
  • Matveeva MV; Siberian State Medical University, Tomsk, Russia.
  • Podchinenova DV; Siberian State Medical University, Tomsk, Russia.
  • Oleynik OA; Siberian State Medical University, Tomsk, Russia.
Biomed Khim ; 69(4): 240-247, 2023 Sep.
Article in En | MEDLINE | ID: mdl-37705485
The universal proteinase inhibitor α2-macroglobulin (α2-MG) exhibiting antiviral and immunomodulatory activities, is considered as an important participant in the infectious process. The activity of α2-MG in the new coronavirus infection and post-covid syndrome (long COVID) has not been studied yet. We examined 85 patients diagnosed with community-acquired bilateral polysegmental pneumonia developed under conditions of a new coronavirus infection SARS-CoV-2. For assessment of the post-COVID period, 60 patients were examined 5.0±3.6 months after the coronavirus infection. Among these patients, 40 people had complications, manifested in the form of neurological, cardiological, gastroenterological, dermatological, bronchopulmonary symptoms. The control group included 30 conditionally healthy individuals with a negative PCR result for SARS-CoV-2 RNA and lack of antibodies to the SARS-CoV-2 virus. The α2-MG activity in serum samples of patients with coronavirus infection dramatically decreased, up to 2.5% of the physiological level. This was accompanied by an increase in the activity of the α1-proteinase inhibitor, elastase- and trypsin-like proteinases by 2.0-, 4.4- and 2.6-fold respectively as compared with these parameters in conditionally healthy individuals of the control. In the post-COVID period, despite the trend towards normalization of the activity of inhibitors, the activity of elastase-like and especially trypsin-like proteinases in serum remained elevated. In overweight individuals, the increase in the activity of trypsin-like proteinases was most pronounced and correlated with an increase in the antibody titer to the SARS-CoV-2 virus. In the post-COVID period, the α2-MG activity not only normalized, but also exceeded the control level, especially in patients with dermatological and neurological symptoms. In patients with neurological symptoms or with dermatological symptoms, the α2-MG activity was 1.3 times and 2.1 times higher than in asymptomatic persons. Low α2-MG activity in the post-COVID period persisted in overweight individuals. The results obtained can be used to monitor the course of the post-COVID period and identify risk groups for complications.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: En Journal: Biomed Khim Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: En Journal: Biomed Khim Year: 2023 Document type: Article Affiliation country: Country of publication: